These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20060898)

  • 1. In-vivo visualization of key molecular processes involved in Alzheimer's disease pathogenesis: Insights from neuroimaging research in humans and rodent models.
    Higuchi M; Maeda J; Ji B; Maruyama M; Okauchi T; Tokunaga M; Ono M; Suhara T
    Biochim Biophys Acta; 2010 Apr; 1802(4):373-88. PubMed ID: 20060898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In-vivo imaging for pursuing molecular cascades in the pathogenesis of neurodegenerative diseases].
    Higuchi M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):929-32. PubMed ID: 20030251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tau Positron Emission Tomography].
    Higuchi M
    Brain Nerve; 2017 Jul; 69(7):819-823. PubMed ID: 28739996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease neuroimaging.
    Whitwell JL
    Curr Opin Neurol; 2018 Aug; 31(4):396-404. PubMed ID: 29762152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.
    Sepulcre J; Grothe MJ; d'Oleire Uquillas F; Ortiz-Terán L; Diez I; Yang HS; Jacobs HIL; Hanseeuw BJ; Li Q; El-Fakhri G; Sperling RA; Johnson KA
    Nat Med; 2018 Dec; 24(12):1910-1918. PubMed ID: 30374196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.
    Buckley RF
    Neurotherapeutics; 2021 Apr; 18(2):709-727. PubMed ID: 33782864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.
    Stancu IC; Vasconcelos B; Terwel D; Dewachter I
    Mol Neurodegener; 2014 Nov; 9():51. PubMed ID: 25407337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of Alzheimer's disease: the long and filamentous road.
    Phinney AL; Horne P; Yang J; Janus C; Bergeron C; Westaway D
    Neurol Res; 2003 Sep; 25(6):590-600. PubMed ID: 14503012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model.
    Roberson ED; Scearce-Levie K; Palop JJ; Yan F; Cheng IH; Wu T; Gerstein H; Yu GQ; Mucke L
    Science; 2007 May; 316(5825):750-4. PubMed ID: 17478722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
    Chu J; Lauretti E; Craige CP; Praticò D
    J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
    J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
    Eisele YS; Duyckaerts C
    Acta Neuropathol; 2016 Jan; 131(1):5-25. PubMed ID: 26715565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.